| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +11.54% | -0.55% | +12.09% | +12.09% | — |
| 14d | 1 | +0.00% | +13.46% | +0.97% | +12.49% | +12.49% | — |
| 30d | 1 | +0.00% | +28.85% | +2.27% | +26.58% | +26.58% | — |
| 60d | 1 | +0.00% | +7.69% | +5.49% | +2.20% | +2.20% | — |
| 90d | 1 | +100.00% | -8.42% | +7.09% | -15.51% | -15.51% | — |
| 180d | 1 | +100.00% | -28.25% | +13.95% | -42.20% | -42.20% | — |
| 1y | 1 | +100.00% | -93.35% | -3.93% | -89.42% | -89.42% | — |
| 2y | 1 | +100.00% | -92.31% | +2.52% | -94.83% | -94.83% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED |
|---|---|---|---|---|---|---|---|
| TXMD THERAPEUTICSMD, INC. | SALE Secretary/CEO of subsidiary | 44,252 | $1.04 | $46.0K | 1,752,703 | May 11, 2021 | May 12, 2021 ↗ |
| TXMD THERAPEUTICSMD, INC. | PURCHASE Secretary/CEO of subsidiary | 103,500 | — | — | 1,796,955 | May 10, 2021 | May 12, 2021 ↗ |
| TXMD THERAPEUTICSMD, INC. | SALE Secretary/CEO of subsidiary | 103,500 | — | — | 207,000 | May 10, 2021 | May 12, 2021 ↗ |
| TXMD THERAPEUTICSMD, INC. | SALE President/Secretary | 179,000 | — | — | 0 | Mar 4, 2021 | Mar 8, 2021 ↗ |
| TXMD THERAPEUTICSMD, INC. | SALE President/Secretary | 29,964 | $1.46 | $43.7K | 1,693,455 | Mar 4, 2021 | Mar 8, 2021 ↗ |
| TXMD THERAPEUTICSMD, INC. | PURCHASE President/Secretary | 179,000 | $0.24 | $43.7K | 1,723,419 | Mar 4, 2021 | Mar 8, 2021 ↗ |
| TXMD THERAPEUTICSMD, INC. | PURCHASEGRANT Stock grant | 360,000 | — | — | 360,000 | Nov 24, 2020 | Nov 27, 2020 ↗ |
| TXMD THERAPEUTICSMD, INC. | SALEGRANT Gift | 434,814 | — | — | 0 | Jun 5, 2020 | Mar 8, 2021 ↗ |
| TXMD THERAPEUTICSMD, INC. | PURCHASEGRANT Stock grant | 310,500 | — | — | 310,500 | Mar 30, 2020 | Apr 1, 2020 ↗ |
| TXMD THERAPEUTICSMD, INC. | PURCHASEGRANT Stock grant | 310,500 | — | — | 310,500 | Mar 30, 2020 | Apr 1, 2020 ↗ |